6Jun2016 Is Bigger Better in Biotech Venture Capital? /Luke Timmerman/0/All, Venture Capital06 Jun 2016 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.